Tacrolimus for Dogs – Topical Immunosuppressant
Tacrolimus is a topical calcineurin inhibitor providing immunosuppression without steroid side effects.
Indications + Protocols
| Indication | Concentration | Frequency |
|---|---|---|
| KCS (dry eye) | 0.02-0.03% ophthalmic | BID to eye(s) |
| Atopic focal | 0.1% Protopic ointment | BID then taper |
| Perianal fistula (GSD) | 0.1% ointment | BID to fistulas |
| Discoid lupus | 0.1% ointment | BID to nasal planum |
| Vitiligo | 0.1% ointment | BID to depigmented |
Onset
- KCS: 1-2 weeks
- Atopic/fistulas: 4-8 weeks
⭐ Advantages over Steroids
- No skin thinning
- No atrophy
- No systemic side effects
- No PU/PD/PP
- Suitable for face, perineum, concave pinnae (steroid-thinning areas)
Perianal Fistula Management (GSDs)
- Tacrolimus 0.1% BID to fistula tracts
- Cyclosporine PO systemic
- Hypoallergenic diet (food allergy component)
- Antibiotic for secondary infection
- Lifelong management typical
- Surgical for severe refractory
⚠ Owner Safety
- Wear nitrile gloves during application
- Wash hands thoroughly after
- Avoid eyes/mouth/genitals
- FDA warning (humans) – theoretical cancer risk
- Pregnant/lactating humans use caution
- Children avoid contact
Side Effects
Common (mild)
- Mild burning/stinging initially
- Temporary erythema
Uncommon
- Skin atrophy (rare, vs steroids)
- Photosensitivity (mild)
- Allergic reactions
NO Steroid Effects
- No PU/PD/PP
- No systemic immunosuppression
When NOT to Use
- Active bacterial/fungal/viral infection at site
- Treat infection first
Frequently Asked Questions
What is tacrolimus used for in dogs?
Multiple TOPICAL immunosuppressive uses: 1) KCS (KERATOCONJUNCTIVITIS SICCA / DRY EYE) – 0.02-0.03% ophthalmic ointment BID; immune-mediated tear gland dysfunction; alternative or adjunct to cyclosporine (Optimmune); 2) ATOPIC DERMATITIS focal lesions – 0.1% Protopic ointment BID; steroid-sparing for face, perineum, concave pinnae; 3) PERIANAL FISTULA (German Shepherd Dog particularly) – 0.1% BID to fistulas; immune-mediated; often combined with cyclosporine PO + hypoallergenic diet; 4) DISCOID LUPUS ERYTHEMATOSUS – nasal planum lesions; 5) VITILIGO / depigmentation; 6) Cutaneous reactive histiocytosis; 7) Other immune-mediated skin conditions. MECHANISM: blocks T-cell activation by inhibiting calcineurin. Immunosuppressive WITHOUT steroid side effects. ONSET: KCS 1-2 weeks; atopic/fistulas 4-8 weeks. Long-term/lifelong typically.
How do I apply tacrolimus to my dog?
STEP-BY-STEP: 1) WEAR NITRILE GLOVES – protect yourself from immunosuppressant; 2) Clean the area (gentle wipe if needed); 3) Apply THIN LAYER or pea-sized amount of ointment to affected area; 4) Massage in gently if possible; 5) REMOVE GLOVES; 6) WASH HANDS THOROUGHLY with soap; 7) Watch dog to prevent immediate licking (Elizabethan collar if needed); 8) Repeat as prescribed. KCS APPLICATION: 1) Gently lower lower eyelid; 2) Apply small bead of ophthalmic ointment in lower conjunctival sac; 3) Close eye briefly to distribute; 4) Avoid touching tube tip to eye; 5) BID typically. PERIANAL FISTULA: 1) Clean perianal area first; 2) Apply to fistula tracts + surrounding skin; 3) BID; 4) Prevent licking with cone. SAFETY: 1) Gloves every application; 2) Wash hands; 3) Don’t apply to broken skin/infected sites without vet guidance; 4) Avoid eyes (except specifically for KCS use ophthalmic product); 5) Avoid mouth/genitals (animal + owner); 6) Pregnant/lactating women extra caution; 7) Children no contact. EXPECT improvement over weeks. Schedule follow-up monitoring.
Are there side effects from tacrolimus in dogs?
Generally WELL-TOLERATED – much fewer side effects than topical steroids. COMMON (mild + temporary): 1) Mild BURNING/STINGING at application site initially; 2) Erythema (redness) temporary; 3) Slight pruritus possible. UNCOMMON: 1) Allergic reactions to ingredients; 2) Skin atrophy (rare, vs steroids); 3) Mild photosensitivity. RARE: 1) Secondary infection at site; 2) Severe local reactions. NO STEROID SIDE EFFECTS – this is the major advantage: 1) NO PU/PD/PP (no systemic absorption); 2) NO panting; 3) NO weight gain; 4) NO infection susceptibility (no systemic immunosuppression); 5) NO Cushingoid features; 6) NO bone loss; 7) NO diabetes risk; 8) Safe long-term. FDA THEORETICAL CANCER RISK: 1) Black box warning on human products (Protopic, Elidel); 2) Based on animal studies at high systemic doses; 3) Not proven with topical use in dogs; 4) Risk-benefit favorable in most cases; 5) Owner caution during application (no human exposure). When to STOP: 1) Severe local reactions; 2) Infection develops; 3) Allergic reaction; 4) No clinical benefit after 8-12 weeks. Excellent option for chronic management when steroids problematic.
Related PuppaDogs Calculators
Continue building your dog’s personalised care plan with these related PuppaDogs calculators:
- Dog Pregnancy / Whelping Due-Date Calculator
- Puppy Weight Predictor (Adult Weight Calculator)
- Heatstroke Risk Calculator for Dogs
- Bloat (GDV) Risk Calculator for Dogs
- Dog Life Expectancy Calculator (Breed, Body Condition, Lifestyle)
- Spay/Neuter Timing Calculator for Dogs (Breed-Specific)
Related Articles & Guides
Read the in-depth PuppaDogs guides that explain the science and clinical context behind this calculator:
References & Further Reading
The dosing ranges and safety information on this page are drawn from the following veterinary references. Always defer to your own veterinarian and the manufacturer’s label for your specific product.
- Plumb DC. Tacrolimus.
- Hillier A. Canine atopic dermatitis – topical therapy.
- Mathews KG et al. Perianal fistula in dogs.
- Berdoulay A et al. Canine KCS treatment.
- Protopic product information.
- PuppaDogs. KCS Calculator, Perianal Fistula Calculator, Atopic Dermatitis Calculator. puppadogs.com.
















